Teva Pharmaceutical Industries Limited company logo
Teva Pharmaceutical Industries Limited logo

TEVA Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$3.30B$74.00M+2.29%

Summary

Current Value
As of today, TEVA annual cash & cash equivalents is $3.30B, up +2.29% on
Historical Performance
TEVA annual cash & cash equivalents is up +52.42% over the past 3 years, and up +67.09% over the past 5 years
All-Time High Comparison
TEVA annual cash & cash equivalents is currently -52.49% below its historical high of $6.95B set on
3-Year Low Comparison
TEVA annual cash & cash equivalents is +17.82% above its 3-year low of $2.80B reached on an earlier date
Sector Comparison
TEVA annual cash & cash equivalents is higher than 97.21% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TEVA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$3.30B+2.3%+52.4%+67.1%+65.4%
Quarterly Cash & Cash Equivalents$2.20B-33.6%-1.0%+20.6%+112.4%
Price$32.40+50.0%+208.0%+192.7%-40.0%
Annual Current Assets$12.55B+0.5%-0.2%-6.8%+4.2%
Annual Total Liabilities$33.61B-4.9%-7.7%-20.8%+130.7%
Annual Working Capital-$244.00M-202.5%-115.8%-16.2%-105.4%
Annual Net Income-$1.97B-220.1%-531.6%-96.8%-198.4%

Cash and Cash Equivalents Highs

TEVA Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$3.30Bat high
5Y$3.30Bat high
All$6.95B-52.5%

Cash and Cash Equivalents Lows

TEVA Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$2.80BN/A+17.8%
5Y$2.17B+52.4%
All$4.60M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$3.30B+2.3%
$3.23B+15.2%
$2.80B+29.4%
$2.17B-0.6%
$2.18B+10.2%
$1.98B+10.8%
YearValueChange
$1.78B+85.0%
$963.00M-2.5%
$988.00M-85.8%
$6.95B+212.0%
$2.23B-

FAQ

  • What is the current annual cash & cash equivalents of TEVA?

    As of today, TEVA annual cash & cash equivalents is $3.30B

  • What is 1-year change in TEVA annual cash & cash equivalents?

    TEVA annual cash & cash equivalents is up +2.29% year-over-year

  • What is 3-year change in TEVA annual cash & cash equivalents?

    TEVA annual cash & cash equivalents is up +52.42% over the past 3 years

  • How far is TEVA annual cash & cash equivalents from its all-time high?

    TEVA annual cash & cash equivalents is currently -52.49% below its historical high of $6.95B set on December 31, 2015

  • How does TEVA annual cash & cash equivalents rank versus sector peers?

    TEVA annual cash & cash equivalents is higher than 97.21% of companies in Healthcare sector

  • When is TEVA next annual earnings release?

    The next annual earnings release for TEVA is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. TEVA Official Website www.tevapharm.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/818686/000119312525266895/0001193125-25-266895-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312525020826/0001193125-25-020826-index.htm
  4. TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
  5. TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva